UK Supreme Court invalidates Eli Lilly patent relating to Cialis
27-03-2019
olm26250 / iStockphoto.com
The UK Supreme Court’s decision in Actavis v Eli Lilly confirms that a multi-factorial judgement should be used to determine whether an invention is obvious or not, lawyers have told WIPR.
To continue reading this article and to access our full archive, digital magazines and special reports you will need a subscription.
Start a subscription today to access the LSIPR website
If you have already subscribed please login.
For multi-user price options, or to check if your company has an existing subscription we can add you into, please email Atif at achoudhury@newtonmedia.co.uk
If you have any technical issues please email tech support.
For access to the complete website and archive choose '12 MONTH SUBSCRIPTION'. For a free, two-week trial select ‘TWO WEEK FREE TRIAL’.
UK Supreme Court, Eli Lilly, Cialis, Actavis, tadalafil, patent validity, prior art, English Court of Appeals, Mewburn Ellis, Powell Gilbert, WilmerHale
